Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: fred hayes who wrote (3554)	11/13/2002 5:55:18 PM
From: Icebrg	Read Replies (1) \| Respond to of 10345

Fred In my opinion the whole deal is actually about the co-promotion. Ligand doesn't want Elan to co-promote as they will not be able to provide the sales force needed. Especially as Elan is narrowing their focus. (Elan might not want the co-promotion either as things stand now). Ligand also realised that their margin under the old agreement was not good enough to bring in a co-promotor. It is because of this that they took the initiative to buy out the 20 % in royalty fees. Erik